Cargando…

Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab

Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Debdeep, Bhatnagar, Anuj, Singh, Gautam K., Sandhu, Sunmeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917490/
https://www.ncbi.nlm.nih.gov/pubmed/35287397
http://dx.doi.org/10.4103/idoj.idoj_223_21
_version_ 1784668557680836608
author Mitra, Debdeep
Bhatnagar, Anuj
Singh, Gautam K.
Sandhu, Sunmeet
author_facet Mitra, Debdeep
Bhatnagar, Anuj
Singh, Gautam K.
Sandhu, Sunmeet
author_sort Mitra, Debdeep
collection PubMed
description Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not responding to conventional therapy. He had earlier developed a drug reaction to dapsone which is considered the drug of choice for this condition. We report successful management of this case with injection rituximab which is a chimeric monoclonal antibody against CD20, which is primarily found on the surface of B cells.
format Online
Article
Text
id pubmed-8917490
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-89174902022-03-13 Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab Mitra, Debdeep Bhatnagar, Anuj Singh, Gautam K. Sandhu, Sunmeet Indian Dermatol Online J Case Report Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not responding to conventional therapy. He had earlier developed a drug reaction to dapsone which is considered the drug of choice for this condition. We report successful management of this case with injection rituximab which is a chimeric monoclonal antibody against CD20, which is primarily found on the surface of B cells. Wolters Kluwer - Medknow 2022-03-03 /pmc/articles/PMC8917490/ /pubmed/35287397 http://dx.doi.org/10.4103/idoj.idoj_223_21 Text en Copyright: © 2022 Indian Dermatology Online Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Mitra, Debdeep
Bhatnagar, Anuj
Singh, Gautam K.
Sandhu, Sunmeet
Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title_full Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title_fullStr Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title_full_unstemmed Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title_short Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
title_sort successful treatment of refractory chronic bullous disease of childhood with rituximab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917490/
https://www.ncbi.nlm.nih.gov/pubmed/35287397
http://dx.doi.org/10.4103/idoj.idoj_223_21
work_keys_str_mv AT mitradebdeep successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab
AT bhatnagaranuj successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab
AT singhgautamk successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab
AT sandhusunmeet successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab